Dimethylarginines and inflammation markers in patients with chronic kidney disease undergoing dialysis

被引：21

作者：

Oner-Iyidogan, Yildiz ^{[1
]}

Oner, Pernur ^{[2
]}

Kocak, Hikmet ^{[2
]}

Gurdol, Figen ^{[2
]}

Bekpinar, Seldag ^{[2
]}

Unlucerci, Yesim ^{[2
]}

Caliskan, Yasar ^{[3
]}

Cetinalp-Demircan, Pinar ^{[2
]}

Kocak, Taner ^{[4
]}

Turkmen, Aydin ^{[3
]}

机构：

[1] Istanbul Univ, Med Lab Programme, Med Serv Training Sch, Istanbul, Turkey

[2] Istanbul Univ, Dept Biochem, Istanbul Fac Med, TR-34093 Istanbul, Turkey

[3] Istanbul Univ, Dept Nephrol, TR-34093 Istanbul, Turkey

[4] Istanbul Univ, Dept Urol, TR-34093 Istanbul, Turkey

来源：

CLINICAL AND EXPERIMENTAL MEDICINE | 2009年 / 9卷 / 03期

关键词：

ADMA; SDMA; Chronic kidney disease; Inflammation; Dimethylarginines; Dialysis; STAGE RENAL-DISEASE; NITRIC-OXIDE; ASYMMETRIC DIMETHYLARGININE; MAINTENANCE HEMODIALYSIS; OXIDATIVE STRESS; L-ARGININE; METABOLISM; PROTEIN; PLASMA; INHIBITOR;

D O I：

10.1007/s10238-009-0035-3

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

The aim of this study was to investigate the pro-oxidant and proinflammatory biomarkers and their relationship with dimethylarginines (DMAs) in patients at various stages of chronic kidney disease (CKD). We studied 114 CKD patients, 36 were hemodialyzed, 41 peritoneal dialyzed and 37 nondialyzed (early stage) CKD patients. The control group consisted of 31 healthy subjects. Plasma levels of asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA), l-arginine, nitric oxide (NO) and proinflammatory cytokines (TNF-alpha and IL-6) were determined, and their relationships with the degree of disease were evaluated. Both DMAs were at high levels in all CKD patients, whereas arginine concentrations were low in patients undergoing dialysis. Elevated TNF-alpha and IL-6 in CKD patients were indicative of ongoing chronic inflammatory state. A significant positive correlation between SDMA and creatinine suggests that plasma SDMA level may be an index for renal function.

引用

页码：235 / 241

页数：7

共 33 条

[1] NG, NG-dimethylarginine and NG, N′G-dimethylarginine in renal insufficiency [J].

Al Banchaabouchi, M ;

Marescau, B ;

Possemiers, I ;

D'Hooge, R ;

Levillain, O ;

De Deyn, PP .

PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 2000, 439 (05) :524-531

[2]

Anderstam B, 1997, J AM SOC NEPHROL, V8, P1437

[3]

Bergstrom J, 1996, Perit Dial Int, V16 Suppl 1, pS181

[4]

Boenisch O, 2002, J NEPHROL, V15, P547

[5]

Brunini Tatiana M. C., 2007, Cardiovascular & Hematological Agents in Medicinal Chemistry, V5, P155

[6]

Descamps-Latscha Beatrice, 1996, P1083, DOI 10.1007/978-0-585-36947-1_46

[7] Dyslipidemias in patients who have chronic kidney disease [J].

Farbakhsh, K ;

Kasiske, BL .

MEDICAL CLINICS OF NORTH AMERICA, 2005, 89 (03) :689-+

[8]

Fleck C, 2001, KIDNEY INT, V78, P14

[9] Protein damage and inflammation in uraemia and dialysis patients [J].

Galli, Francesco .

NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 :20-36

[10] Acute and chronic inflammation in pediatric patients receiving hemodialysis [J].

Goldstein, SL ;

Currier, H ;

Watters, L ;

Hempe, JM ;

Sheth, RD ;

Silverstein, D .

JOURNAL OF PEDIATRICS, 2003, 143 (05) :653-657

← 1 2 3 4 →